Feng Chen

US Patent:

20130043119, Feb 21, 2013

Filed:

Aug 17, 2012

Appl. No.:

13/588941

Inventors:

Yashen Xia - Newton MA, US
Feng Chen - Belmont MA, US

International Classification:

B01J 19/08

US Classification:

204165, 42218604, 42218603

Abstract:

Provided are electronegative-ion-aided methods and apparatus to achieve reduction of carbon dioxide gas into useful products. In one embodiment, using different methods of discharge, the electronegative gases forms non-equilibrium electronegative ions, so that carbon dioxide reduction occurs for the production of organic compounds. When carbon dioxide is introduced into the container containing at least one electronegative gas, such as water, ammonia, bromine or iodine vapor, it reacts to form organic compounds, such as ethanol, methanol, and oxalic acid in the case of water, urea in the case of ammonia, and tetraiodomethane in the case of iodine.

US Patent:

51149052, May 19, 1992

Filed:

Mar 8, 1990

Appl. No.:

7/490752

Inventors:

Bill C. Giessen - Cambridge MA
Robert S. Markiewicz - Lexington MA
Feng Chen - Boston MA

Assignee:

Northeastern University - Boston MA

International Classification:

H01L 3912
B06B 102

US Classification:

505 1

Abstract:

A method of processing polycrystalline material by performing multi-axis crystal alignment utilizing anisotropies in the crystalline structure including the step of providing a polycrystalline material in a fluid suspension or malleable form having a magnetic moment. An external force to which the material is reactive is applied to align the individual crystals along a first axis. A magnetic field is applied to orient the magnetic moment of the crystals along a second axis, transverse to the first axis. The crystalline material may have a magnetic moment associated with a rare earth element of the material.

US Patent:

20220378924, Dec 1, 2022

Filed:

Jul 18, 2022

Appl. No.:

17/867025

Inventors:

- Monmouth Junction NJ, US
Aranapakam M. VENKATESAN - Rego Park NY, US
Feng CHEN - Princeton NJ, US
Fei WU - Plainsboro NJ, US
Melik Ziya TÜRKER - Princeton NJ, US
Gregory Paul ADAMS - Hatboro PA, US
Francis Y.F. LEE - Yardley PA, US

International Classification:

A61K 47/55
A61K 47/69
A61K 47/60
A61K 47/54
A61P 35/00

Abstract:

The disclosure relates to nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates, and methods of making and using them to treat cancer.

US Patent:

20210121569, Apr 29, 2021

Filed:

Apr 29, 2019

Appl. No.:

17/051928

Inventors:

- New York NY, US
- Ithaca NY, US
Snehal G. Patel - New York NY, US
Feng Chen - New York NY, US
Brian Madajewski - New York NY, US
Daniella Karassawa Zanoni - New York NY, US

International Classification:

A61K 41/00
A61K 47/69
A61K 51/12

Abstract:

Described herein are systems and methods for particle-based photodynamic therapy (PDT) for the treatment of diseases such as cancer of the oral cavity and/or ovarian cancer metastases along the lining of the pelvis. The technology includes an imaging system (e.g., a multichannel imaging camera) configured to perform diagnostic and/or therapeutic treatment on diseased tissue. In certain embodiments, the imaging system comprises one or more excitation sources (e.g., one or more lasers) to assess and/or treat diseased tissue.